Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Innovation Pharmaceuticals Inc./ 10-Q

Quarterly Report · 10-Q

Innovation Pharmaceuticals Inc.

IPIXOTCEQUITYCurrent

Quarterly Report

Filed Feb 15, 2023Accepted Feb 15, 2023, 11:05 AM ESTCIK 1355250Accession 0001477932-23-001071
View company →Permanent SEC source ↗
Share

Company context

Current securities

IPIXOTC · EQUITY · Current

Recent company filings

  1. 8-K filingFeb 1, 2024
  2. 8-K filingDec 5, 2023
  3. 10-Q filingNov 20, 2023
  4. NT 10-Q filingNov 15, 2023
  5. 8-K filingOct 30, 2023

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗